DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,174,074,047 | +0.3% | 4,732,254 | -3.0% | 2.52% | +6.2% |
Q2 2023 | $1,170,676,694 | -5.7% | 4,877,820 | -1.0% | 2.38% | -8.7% |
Q1 2023 | $1,241,792,370 | -6.5% | 4,926,965 | -1.5% | 2.60% | -7.7% |
Q4 2022 | $1,327,624,775 | -2.8% | 5,001,977 | -5.0% | 2.82% | -6.8% |
Q3 2022 | $1,365,745,000 | -1.9% | 5,266,273 | -3.9% | 3.02% | +3.1% |
Q2 2022 | $1,392,224,000 | -14.7% | 5,478,344 | -1.5% | 2.93% | -1.3% |
Q1 2022 | $1,632,736,000 | -32.4% | 5,561,844 | -24.3% | 2.97% | -27.3% |
Q4 2021 | $2,414,810,000 | +10.5% | 7,348,498 | +2.1% | 4.09% | -1.1% |
Q3 2021 | $2,186,242,000 | +12.0% | 7,195,865 | -1.3% | 4.14% | +10.8% |
Q2 2021 | $1,952,011,000 | +18.8% | 7,293,577 | -0.4% | 3.73% | +11.2% |
Q1 2021 | $1,642,687,000 | +6.3% | 7,321,046 | +4.8% | 3.36% | -12.6% |
Q4 2020 | $1,545,746,000 | -4.0% | 6,983,261 | -6.7% | 3.84% | -21.1% |
Q3 2020 | $1,610,309,000 | +22.6% | 7,482,041 | +0.8% | 4.86% | +10.2% |
Q2 2020 | $1,312,968,000 | +32.5% | 7,425,031 | +3.7% | 4.41% | +5.5% |
Q1 2020 | $991,071,000 | -10.1% | 7,160,403 | -0.3% | 4.18% | +15.5% |
Q4 2019 | $1,102,091,000 | +62.1% | 7,180,679 | +52.5% | 3.62% | +0.5% |
Q3 2019 | $679,916,000 | +3.8% | 4,707,582 | +2.7% | 3.60% | -1.5% |
Q2 2019 | $655,158,000 | +6.3% | 4,584,088 | -1.8% | 3.66% | -0.1% |
Q1 2019 | $616,235,000 | +27.4% | 4,667,739 | -0.5% | 3.66% | +12.1% |
Q4 2018 | $483,812,000 | -9.0% | 4,691,736 | -4.1% | 3.27% | +5.5% |
Q3 2018 | $531,480,000 | +13.6% | 4,891,222 | +3.1% | 3.10% | +7.5% |
Q2 2018 | $467,968,000 | +7.4% | 4,742,278 | +6.5% | 2.88% | -1.6% |
Q1 2018 | $435,877,000 | +9.2% | 4,451,816 | +3.5% | 2.93% | +5.7% |
Q4 2017 | $399,263,000 | +14.1% | 4,301,473 | +5.4% | 2.77% | +1.9% |
Q3 2017 | $349,931,000 | +35.7% | 4,079,406 | +33.5% | 2.72% | +26.2% |
Q2 2017 | $257,922,000 | +6.5% | 3,056,312 | +7.9% | 2.15% | -2.3% |
Q1 2017 | $242,265,000 | +12.3% | 2,832,519 | +2.2% | 2.20% | +4.5% |
Q4 2016 | $215,705,000 | +3.8% | 2,771,135 | +4.5% | 2.11% | -2.3% |
Q3 2016 | $207,824,000 | +28.7% | 2,651,157 | +65.8% | 2.16% | +23.3% |
Q2 2016 | $161,490,000 | +240.6% | 1,598,913 | +219.9% | 1.75% | +218.2% |
Q1 2016 | $47,410,000 | +11.1% | 499,790 | +8.8% | 0.55% | +6.8% |
Q4 2015 | $42,658,000 | – | 459,285 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |